David Hoang Analyst PerformanceDirector, Senior Analyst, Biotechnology at Deutsche Bank AktiengesellschaftDavid Hoang is a stock analyst at Deutsche Bank Aktiengesellschaft in the healthcare sector, covering 16 publicly traded companies. Over the past year, David Hoang has issued 29 stock ratings, including buy and hold recommendations. While full access to David Hoang's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Hoang's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings44 Last 1 YearsBuy Recommendations69.05% 29 Buy RatingsCompanies Covered16 Unique Companies Ratings Distribution42RatingsDistribution of strong buy, buy, hold, and sell ratings by David Hoang.RatingPercentageCount Strong Buy0.0%0 ratings Buy69.0%29 ratings Hold28.6%12 ratings Sell2.4%1 ratingsOut of 42 total stock ratings issued by David Hoang at Deutsche Bank Aktiengesellschaft, the majority (69.0%) have been Buy recommendations, followed by 28.6% Hold and 2.4% Sell.Best & Worst CallsBest Call0000.0%PRAXFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BHVNFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ93.8% of companies on NASDAQ15 companiesNYSE6.3% of companies on NYSE1 companyDavid Hoang, an analyst at Deutsche Bank Aktiengesellschaft, currently covers 16 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare16 companies100.0%David Hoang of Deutsche Bank Aktiengesellschaft specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY11 companies68.8%PHARMACEUTICALS5 companies31.3% David Hoang's Ratings History at Deutsche Bank Aktiengesellschaft Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsXENEXenon Pharmaceuticals9/18/2026Reiterated Rating$57.35$46.00Hold$0.0000.00% ROIXENEXenon Pharmaceuticals9/18/2026Downgrade$57.35$46.00Hold$0.0000.00% ROIRYTMRhythm Pharmaceuticals8/28/2026Initiated Coverage$112.53$120.00Hold$0.0000.00% ROISYRESpyre Therapeutics8/26/2026Lower Price Target$107.36$127.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals8/25/2026Boost Price Target$30.16$38.00Buy$0.0000.00% ROIATAIAtai Beckley8/12/2026Downgrade$7.21$8.00Hold$0.0000.00% ROIATAIAtai Beckley8/12/2026Downgrade$7.21$8.00Hold$0.0000.00% ROIHRMYHarmony Biosciences8/5/2026Reiterated Rating$38.01$39.00Hold$0.0000.00% ROIKYMRKymera Therapeutics7/30/2026Initiated Coverage$105.25$120.00Hold$0.0000.00% ROIDNLIDenali Therapeutics7/16/2026Boost Price Target$23.02$35.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. HRMYHarmony Biosciences6/30/2026Boost Price Target$36.22$36.00Hold$0.0000.00% ROISYRESpyre Therapeutics6/23/2026Boost Price Target$101.27$135.00Buy$0.0000.00% ROIAPGEApogee Therapeutics6/22/2026Downgrade$132.55$135.00Hold$0.0000.00% ROISYRESpyre Therapeutics6/4/2026Boost Price Target$73.52$115.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines6/2/2026Reiterated Rating$335.16$374.00Buy$0.0000.00% ROISYRESpyre Therapeutics5/12/2026Reiterated Rating$76.53$102.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics5/5/2026Set Price Target$230.28$280.00$0.0000.00% ROISYRESpyre Therapeutics4/14/2026Boost Price Target$63.27$88.00Buy$0.0000.00% ROIATAIAtai Beckley3/27/2026Initiated Coverage$3.54$12.00Buy$0.0000.00% ROIXENEXenon Pharmaceuticals3/10/2026Boost Price Target$62.76$90.00Buy$0.0000.00% ROIHRMYHarmony Biosciences2/23/2026Downgrade$29.16$31.00Hold$0.0000.00% ROIPRAXPraxis Precision Medicines2/20/2026Reiterated Rating$331.61$412.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines12/12/2025Set Price Target$271.23$313.00$0.0000.00% ROIAPGEApogee Therapeutics12/9/2025Initiated Coverage$74.74$103.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines12/5/2025Reiterated Rating$189.97$303.00Buy$0.0000.00% ROIALKSAlkermes11/13/2025Lower Price Target$31.41$45.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines10/17/2025Reiterated Rating$162.71$280.00Buy$0.0000.00% ROISYRESpyre Therapeutics9/26/2025Initiated Coverage$15.61$43.00Buy$0.0000.00% ROIHRMYHarmony Biosciences9/25/2025Lower Price Target$27.00$36.00Buy$0.0000.00% ROISRPTSarepta Therapeutics8/15/2025Boost Price Target$21.76$12.00Sell$00.0000.00% ROIJAZZJazz Pharmaceuticals7/15/2025Initiated Coverage$111.44$152.00Buy$000.0000.00% ROIHRMYHarmony Biosciences7/10/2025Reiterated Rating$34.35$55.00Buy$00.0000.00% ROISRPTSarepta Therapeutics6/17/2025Lower Price Target$21.94$25.00Hold$00.0000.00% ROIACADACADIA Pharmaceuticals5/21/2025Upgrade$21.69$35.00Buy$00.0000.00% ROIALKSAlkermes3/27/2025Boost Price Target$33.69$52.00Buy$00.0000.00% ROISRPTSarepta Therapeutics3/19/2025Lower Price Target$73.54$99.00Hold$00.0000.00% ROIALKSAlkermes2/11/2025Initiated Coverage$31.23$40.00Buy$00.0000.00% ROIAVDLAvadel Pharmaceuticals2/11/2025Initiated Coverage$9.09$12.00Buy$00.0000.00% ROIAXSMAxsome Therapeutics2/11/2025Initiated Coverage$127.08$176.00Buy$000.0000.00% ROIBHVNBiohaven2/11/2025Initiated Coverage$38.25$65.00Buy$00.0000.00% ROIMajor Buy Alert Issued for September 30th (Ad)Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 people worldwide. His system has flagged a handful of stocks worth watching ahead of September 30th. See which stocks his AI research platform is flagging right now.See which stocks his AI research platform is flagging nowDNLIDenali Therapeutics2/11/2025Initiated Coverage$20.88$31.00Buy$00.0000.00% ROIHRMYHarmony Biosciences2/11/2025Initiated Coverage$37.99$55.00Buy$00.0000.00% ROIPRAXPraxis Precision Medicines2/11/2025Initiated Coverage$84.85$111.00Buy$000.0000.00% ROIXENEXenon Pharmaceuticals2/11/2025Initiated Coverage$39.25$67.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageRoyal Bank Of CanadaWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
